植込型補助人工心臓がもたらす経済効果

Size: px
Start display at page:

Download "植込型補助人工心臓がもたらす経済効果"

Transcription

1 特集 植込型補助人工心臓の時代を迎えて Tomoyuki TAKURA, Shunei KYO, Yoshiki SAWA 1. はじめに value well-being socio economics 2. 医療技術の臨床経済的評価の概念 1) 医療技術の臨床経済価値の基本的な考え方 function cost performance value outcome utility 1 outcome cost performance value 1) 2) 医療技術の臨床経済的な価値評価の方法論 2 著者連絡先 takura@heip.med.osaka-u.ac.jp 1 効用 utility

2 utility 1.0 utility year Qalys Cost (-) Therapy(+) Doubtful Dominant base Therapy(-) Survival time (quantitative profit), Quality of life (qualitative profit) Utility (-) Utility (+) 0.0 Inferior Effective pre treatment post time 図 1 in press 2) utility 1 Qaly: quality adjusted life years 図 1 2) / 1 1 incremental cost utility ratio: ICUR ICUR / 図 2 図 2 3) 3) 医療技術が有する価値を貨幣換算する議論 ICUR WTP: Cost ( + ) willingness to pay 2 1 Qaly 3 5 US$ 4) Qaly 1 Qaly 5),6) 600 benefit consideration ICUR Performances are compared between medical technology Value of medicine is discussed with acceptance of public health insurance 図 2 2 Incremental Cost Utility Ratio ICUR 1340: 16-7, ) 2 支払意思額 stated preference

3 表 1 US$/Qaly Therapy Range of Cost-Utility Performance: US$/Qaly Notes Reference Usual clinical ventricular assist system 78, ,100 BTT/LTCS 7) 11) Implantable clinical ventricular assist 198, ,200 HeartMate, BTT/DT, 13),14) system second-generation significantly increases survival and QOL but high cost Transplantation 29,000 57,000 12) BTT: bridge to transplantation, LTCS: long-term chronic support, DT: destination therapy, QOL: quality of life. Qaly Qaly prospective health rule Qaly fair inning rule rule of rescue 3. 植込型補助人工心臓の経済評価の試行 1) 植込型補助人工心臓の費用効用分析 2. ventricular assist system: VAS 表 1 7) 11) bridge to transplantation: BTT 78, ,100 US$/Qaly quality of life: QOL QOL 29,000 57,000 US$/Qaly 12) DuraHeart EVAHEAR T ml ),14) BTT destination therapy: DT HeartMate Qaly QOL 198, ,200 US$/Qaly DT 2) 技術イノベーションの社会経済的評価の概念 value value of medicine 1 3 図

4 To urge technological innovation 3 index of socioeconomics Improvement of burden OS, QOL, etc. Evaluation of medical technology Reduction of social cost Budget impact, etc. Growth of economic condition GDP, trade balance, etc. discusses technology as economical value 図 : 16-7, ) Improvement of burden Reduction of social cost Growth of economic condition 15) 3 3) 植込型補助人工心臓の社会経済的な効果 2 表 2 3 7) 33) / ,166 5,402 2, Qaly Qaly 881 /3 3,326 /3 VAS 70 /3 207 /3 3,027 /3 1 1, おわりに

5 表 2 Improvement of burden Reduction of social cost Growth of economic condition Total socioeconomics A B C Labor productivity-national contribution C : impact Medical cost Public sector, etc. B : imapct Utility-Benefit Spirit of cooperation, etc. A : impact Therapy Model Model Model , ,820.0 i 36 ƒ i I, Ur, Br, Sr, S, A, N i i 36 ƒi C, Sr, S, A i 1 Conservative Treatment Medicine i 36 ƒ i W, Rr, Sr, S, A i 1 4, , ,020.0 I : Annual income, Ur: Unemployment rate, Br: Comeback ratio to work, Sr: Survival rate, S: Sex, A: Age, N: National contribution rate, i: time of post treatment monthly C: surgery, hospital, outpatient, Sr: Survival rate, S: Sex, A: Age, i: time of post treatment monthly W: WTP-Qaly, Rr: Return ratio to society, Sr: Survival rate, S: Sex, A: Age, i: time of post treatment monthly Usual Clinical Ventricular Assist System 8, , ,744.8 Implantable Clinical Ventricular Assist System secondgeneration , ,440.0 vs. Conservative Treatment Medicine 8,660.9 vs. Conservative Treatment Medicine vs. Conservative Treatment Medicine , ,454.0 vs. Usual Clinical Ventricular Assist System 4,117.6 vs. Usual Clinical Ventricular Assist System vs. Usual Clinical Ventricular Assist System Socioeconomic gain of Implantable Clinical Ventricular Assist System The labor production is not converted into the tax and insurance fee. WTP: willingness to pay, QALY: quality adjusted life year. 18 7) 25) 7 26) 33) 文献 1) 77: , ) in press 3) 1340: 16-7, ) Guidelines Manual-Appraising Orphan Drugs, NICE, Available from: 5) 40(Suppl : S-107, ) 1QALY 16: , ) Hutchinson J, Scott DA, Clegg AJ, et al: Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Expert Rev Cardiovasc Ther 6: , ) Sharples LD, Dyer M, Cafferty F, et al: Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Hear t Lung Transplant 25: , ) Mahle WT, Ianucci G, Vincent RN, et al: Costs associated with ventricular assist device use in children. Ann Thorac Surg 86: , ) Sharples L, Buxton M, Caine N, et al: Evaluation of the ventricular assist device programme in the UK. Health Technol Assess 10: 1-119, iii-iv, ) Clegg AJ, Scott DA, Loveman E, et al: The clinical and costeffectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess 9: 1-132, iii-iv, ) 44: 60-8, ) Rogers JG, Bostic RR, Tong KB, et al: Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail 5: 10-6, ) Moreno SG, Novielli N, Cooper NJ: Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant, 2011 [Epub ahead of print] 15) 1338: 14-5,

6 16) 218: , ) 37: , ) 15: 246, ) 239: 193-8, ) 62: 67-73, ) 36: 244-7, ) Hear t View 12: , ) 44: 10-7, ) Stevenson LW: Clinical use of inotropic therapy for heart failure: looking backward or forward?. Circulation 108: 492-7, ) Slaughter MS, Rogers JG, Milano CA, et al: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361: , ) ) ) ) ) ) ) )

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

4703ALL01

4703ALL01 473201010 *** (1999) 16 2017 20023 2 1 2 1220 (1999a),(1999b) (1998), (2002) (2003)(1999)(2003) Conjoint Analysis Conjoint Analysis Willingness to PayStandard gamble Time trade-off Rating Scale Willingness

More information

2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun

2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun 10 1-14 2014 1 2 3 4 2 1 2 3 4 Web PubMed elbow pain baseball elbow little leaguer s elbow acupuncture electric acupuncture 2003 2012 10 39 32 Web PubMed Key words growth stage elbow pain baseball elbow

More information

食道がん化学放射線療法後のsalvage手術

食道がん化学放射線療法後のsalvage手術 2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

60 Vol. 44 No. 1 2 準市場 化の制度的枠組み: 英国 教育改革法 1988 の例 Education Reform Act a School Performance Tables LEA 4 LEA LEA 3

60 Vol. 44 No. 1 2 準市場 化の制度的枠組み: 英国 教育改革法 1988 の例 Education Reform Act a School Performance Tables LEA 4 LEA LEA 3 Summer 08 59 I はじめに quasi market II III IV V 1 II 教育サービスにおける 準市場 1 教育サービスにおける 準市場 の意義 Education Reform Act 1988 1980 Local Education Authorities LEA Le Grand 1991 Glennerster 1991 3 1 2 3 2 60 Vol. 44

More information

_’£”R‡Ù‡©

_’£”R‡Ù‡© 29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)

More information

WHO Library Cataloguing in Publication Data 2003, Wilkinson,Richard Marmot,Michael Social determinants of health SDH The social gradient Stress Early life Social exclusion Work Unemployment Social support

More information

Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery

Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery, Osaka Kosei-Nenkin Hospital K. Izawa and S. Wakitani

More information

206“ƒŁ\”ƒ-fl_“H„¤‰ZŁñ

206“ƒŁ\”ƒ-fl_“H„¤‰ZŁñ 105 206 105 117 2007 105 3 LCC 110 106 LCC 111 106 1 111 107 2 112 1 107 3 114 2 108 115 109 115 1 LCC 110 Summary 117 2 110 2005 3 LCC 19 3 6 LCC LCC LCC 1.0 2 3, 1997 B/C Cost Benefit Ratio 1997 NPV

More information

202

202 201 Presenteeism 202 203 204 Table 1. Name Elements of Work Productivity Targeted Populations Measurement items of Presenteeism (Number of Items) Reliability Validity α α 205 α ä 206 Table 2. Factors of

More information

1. 2. (Rowthorn, 2014) / 39 1

1. 2. (Rowthorn, 2014) / 39 1 ,, 43 ( ) 2015 7 18 ( ) E-mail: sasaki@econ.kyoto-u.ac.jp 1 / 39 1. 2. (Rowthorn, 2014) 3. 4. 5. 6. 7. 2 / 39 1 ( 1). ( 2). = +. 1. g. r. r > g ( 3).. 3 / 39 2 50% Figure I.1. Income inequality in the

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11

2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11 1-122013 1 2 1 2 20 2,000 2009 12 1 2 1,362 68.1 2009 1 1 9.5 1 2.2 3.6 0.82.9 1.0 0.2 2 4 3 1 2 4 3 Key words acupuncture and moxibustion Treatment with acupuncture, moxibustion and Anma-Massage-Shiatsu

More information

Rinku General Medical Center

Rinku General Medical Center Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines

More information

九州大学学術情報リポジトリ Kyushu University Institutional Repository 高齢心疾患患者における運動機能と身体的フレイル評価の意義 内藤, 紘一九州大学大学院人間環境学府 京都橘大学健康科学部 熊谷, 秋三九州大学大学院人間環境学府 九州大学基幹教育院 九州大

九州大学学術情報リポジトリ Kyushu University Institutional Repository 高齢心疾患患者における運動機能と身体的フレイル評価の意義 内藤, 紘一九州大学大学院人間環境学府 京都橘大学健康科学部 熊谷, 秋三九州大学大学院人間環境学府 九州大学基幹教育院 九州大 九州大学学術情報リポジトリ Kyushu University Institutional Repository 高齢心疾患患者における運動機能と身体的フレイル評価の意義 内藤, 紘一九州大学大学院人間環境学府 京都橘大学健康科学部 熊谷, 秋三九州大学大学院人間環境学府 九州大学基幹教育院 九州大学キャンパスライフ 健康支援センター https://doi.org/10.15017/1800856

More information

自殺の経済社会的要因に関する調査研究報告書

自殺の経済社会的要因に関する調査研究報告書 17 1 2 3 4 5 11 16 30,247 17 18 21,024 +2.0 6 12 13 WHO 100 14 7 15 2 5 8 16 9 10 17 11 12 13 14 15 16 17 II I 18 Durkheim(1897) Hamermesh&Soss(1974)Dixit&Pindyck(1994) Becker&Posner(2004) Rosenthal(1993)

More information

36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi

36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi 36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan

More information

_念3)医療2009_夏.indd

_念3)医療2009_夏.indd Evaluation of the Social Benefits of the Regional Medical System Based on Land Price Information -A Hedonic Valuation of the Sense of Relief Provided by Health Care Facilities- Takuma Sugahara Ph.D. Abstract

More information

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin

5 I The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthenin 5 I. 3 1 1990 2 The Current Situation and Future Prospects of the North Korean Economy presented at the 2014 Korea Dialogue Conference on Strengthening North Pacific Cooperation organized by the East-West

More information

2 1 20 34 20 60 65 1) 1 2 3 2 3 2 2008 3 1 2,035 2 3,457 3 1,063 6,555 2) 2006 3 460 1 2 1996 2 1997 2003 1 1 2 1 3-2 -

2 1 20 34 20 60 65 1) 1 2 3 2 3 2 2008 3 1 2,035 2 3,457 3 1,063 6,555 2) 2006 3 460 1 2 1996 2 1997 2003 1 1 2 1 3-2 - No.43 2008 12 Abstract The national pension system aims to provide a common "basic pension" to all residents in Japan. So, all people aged between 20 and 59 living in Japan must join the National Pension

More information

untitled

untitled 1988 2000 2002 2004 2006 2008 IFN Lamivudine Adefovir Entecavir 1 Total number 560 Sex (male/female) 424/136 Age (years)* 38 (15-68) Duration of treatment (weeks)* 26 (1-592) Follow-up time (years) 75(05-21

More information

indd

indd 12 61 1 2011 原著 1)2)5) 1) 1)2) 1)2)5) 1)3)5) 1)2) 1)2)5) 1)2) 1)2) 2) 2) 4) 1) 1) 2) 3) 4) 5) 2010 10 6 2010 12 6 A Comparative Study of the Effect and Discomfort Produced by Pharyngeal Anesthesia with

More information

.y101211-4.z...Z.I.v24...ren

.y101211-4.z...Z.I.v24...ren 17 1 2007 2008 3 G D P GDP 564,606 5,158,515 10.9 375,538 1,420,657 26.6 21 350351 18 19 52.71 40.32 93.03 52.7 40.3 2009 38.9 2007 49.2 2009 12 1 15.9 10.8 7.7 13.7 6.8 13.9 4.8 6.1 3.7 5.8 2009 12 1

More information

Ishi

Ishi Ishi HPhttp: // www.mof.go.jp / jouhou / syuzei / siryou /.htm.. or ERTA, TRA ERTA Economic Recovery Tax Act TRA Tax Reform Act Mroz Triest Lindsey Burtless Navrati Lindsey Burtless Navrati CPS Current

More information

I

I 九州大学学術情報リポジトリ Kyushu University Institutional Repository 熊本県水俣市の限界集落における耕作放棄地の拡大とその要因 寺床, 幸雄九州大学大学院人文科学府 : 博士後期課程 : 農村 農業地理学 Teratoko, Yukio http://hdl.handle.net/2324/20036 出版情報 : 地理学評論. 82 (6), pp.588-603,

More information

公務員人件費のシミュレーション分析

公務員人件費のシミュレーション分析 ESRI Discussion Paper Series No.256 December 2010 Economic and Social Research Institute Cabinet Office Tokyo, Japan The views expressed in ESRI Discussion Papers are those of the authors and not those

More information

_16_.indd

_16_.indd well-being well-being well-being Cantril Ladder well-being well-being Cantril Self-Anchoring Striving Scale Cantril Ladder Ladder Ladder awellbeing well-being well-being Gallup World Poll World Database

More information

(1) 24 ICU (2)X (3)ICU (4)PMS E/S E/S 1.4 DGMC , AD 1 A 4 2

(1) 24 ICU (2)X (3)ICU (4)PMS E/S E/S 1.4 DGMC , AD 1 A 4 2 2003 7 1.1 1994 5 *1 94 E/S *2 5 1 1.2 1.3 1 P3 2 1 (1) 24 ICU (2)X (3)ICU (4)PMS E/S E/S 1.4 DGMC 1.5 47 700 46 1,900 1996 12 1996 12 2.7 30 10 2001 12 2.1 2.1.1. AD 1 A 4 2 60 B 5 12 B DGMC 12 B 2.1.2.

More information

276-E12001.indd

276-E12001.indd 2012; 54 (6): 276 285 91.6% 1 1 91.6% 2 142 54 196 (1) (2) 6 (3) (4) 60 1 54.2% 91.6% 1 6,226,192 8,418,514 65,945 300,898 ROI 933% 2012; 54 (6): 276 285 doi: 10.1539/sangyoeisei.E12001 1,2) 2) 3) 3 5)

More information

研究成果報告書

研究成果報告書 21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

More information

産業・企業レベルデータで見た日本の経済成長.pdf

産業・企業レベルデータで見た日本の経済成長.pdf 2003 11 10 IT IT JIP JCER ) 2003 CD-ROM http://www.esri.go.jp/jp/archive/bun/bun170/170index. html 1 JIP Jorgenson, Mun, andstiroh (2002) GDP 2 3 1951 1954 1957 1960 1963 1966 1969 1972 1975 1978 1981

More information

A Message From President 2

A Message From President 2 A Message From President 2 Top Information 3 Top Information 4 A View Point 5 Annual Report 2 Financial Highlight 7, 5, 12, 6, 5, 4, 3, 2, 1, 4, 3, 2, 1, 1, 8, 6, 4, 2, 6 5, 2, 8 4, 1,5 6 3, 2, 1, 1, 5

More information

21-07_後藤論文.smd

21-07_後藤論文.smd 2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive

More information

静 脈 学 Table 1 Patient characteristics Symptom Case Age Sex Site PE Cause Treatment 1 44 M RSCV swelling (+) unknown UK, anticoaglant patent Result 2 5

静 脈 学 Table 1 Patient characteristics Symptom Case Age Sex Site PE Cause Treatment 1 44 M RSCV swelling (+) unknown UK, anticoaglant patent Result 2 5 Paget-Schroetter 3 Paget-Schroetter 3 1 1 1 3 86 42 Paget-Schroetter 2013 24 1 71- Paget-Schroetter 3 Table 1 1 44 1 CT 1 2012 4 19 CT CT Fig. 1 2 54 CT Fig. 2 71 静 脈 学 Table 1 Patient characteristics

More information

産業構造におけるスポーツ産業の範囲に関する研究Ⅰ

産業構造におけるスポーツ産業の範囲に関する研究Ⅰ Abstract This study is emphasizes that the sports industry holds big weight with the economy of our country but tends to be disregarded The study sees it us a peculiar industry which has ports of both

More information

untitled

untitled 2008/04/27 1. 1 2 staticdynamics etc 3 Hedberg A, Carlberg EB, Forssberg H, Hadders-Algra M. Development of postural adjustments in sitting position during the first half year of life. Dev Med Child Neurol.

More information

E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian

More information

再生医科学研究所年報 Annual Report of the Institute for Frontier Medical Sciences Kyoto University Institute for Frontier Medical Sciences 1 2 3 4 5 6 Institute for Frontier Medical Sciences 1 Annual Report 2011

More information

精神障害者

精神障害者 13 ACT 156-8585 2-1-8 TEL03-3304-5701 14 10 30 ACTassertive community treatment 1 ACT ACT ACT ACT Fidelity ScaleACT ACT ACT ACT ACT Fidelity 2000, 2001; 1994 Tessler & Gamache 2000 14 1 2002 1986 1994

More information

Winter 2009 No Lower Earnings Limit

Winter 2009 No Lower Earnings Limit 特集 : イギリスの社会保障 - ニューレイバーの 10 年 イギリスの公的 私的年金制度改革 丸谷浩介 I 1 50 1997 II 1. 2 15 Winter 2009 No. 169 8 3 4 1999 1989 8 2. 4 1 2 1 1992 6 16 Lower Earnings Limit1 65 60 1 2 16 2.40 16 2 1 5 1 2 3. 6 1970 State

More information

,.,.,,.,,.,,,,,.,,,.,.,,,.,,.,,,,,,,.,,.,,.,,,,.,,,,,,.,,.,,.,.,,,,,,.,,,,.

,.,.,,.,,.,,,,,.,,,.,.,,,.,,.,,,,,,,.,,.,,.,,,,.,,,,,,.,,.,,.,.,,,,,,.,,,,. J. of Population Problems. pp. * * * * *.,,,,.,.,.,,..,..,..,,..,., ,.,.,,.,,.,,,,,.,,,.,.,,,.,,.,,,,,,,.,,.,,.,,,,.,,,,,,.,,.,,.,.,,,,,,.,,,,. ,,,.,,,..,,.,.,,,,,..,,,.,,,,,,.,,.,,,.,.,.,.,,,.,,.,,.,.,,.,.

More information

社会システム研究25_ 徐林.indd

社会システム研究25_ 徐林.indd D E-mail xlh@sass.org.cn Employer-based healthcare delivery system ........................................ U.S. Census Bureau Income, Poverty, and Health Insurance Coverage in the United States:Issued

More information

Influences of mortality from main causes of death on life expectancy. \ An observation for the past 25 years, 1950-1975, in Japan \ Takao SHIGEMATSU* and Zenji NANJO** With the Keyfitz-Nanjo method an

More information

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004 The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale

More information

untitled

untitled 19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- twatanab@oncoloplan.com http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase

More information

生命倫理_Vol.25_No.1

生命倫理_Vol.25_No.1 A consideration of the relationship between Advance Care Planning and Advance Directives, Based on evidence from the U.S.A. Advance Directives AD AD 1 1990 2 AD 2012 2001 3 AD Advance Care Planning ACP

More information

@08460025ヨコ/伊東 217号

@08460025ヨコ/伊東 217号 A B B A B A B A B stratification inequality Marmot, Smith, Why are the Japanese living longer?, British Medical Journal, 1989 Kondo, Kawachi, Subramanian, Takeda, Yamagata Do social comparisons

More information

日本消化器外科学会雑誌第30巻第3号

日本消化器外科学会雑誌第30巻第3号 Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment

More information

9.プレゼン資料(小泉)R1

9.プレゼン資料(小泉)R1 1 Me-DigIT 2 TRO, TMECH Interesting Readings IJMRCAS, TUFFC The Most 3., etc.. etc.. etc. 4 TRO09 5 J TRO09 The Most Interesting Readings J http://www.learner.org/interactives/renaissance/printing.html

More information

履  歴  書

履  歴  書 ,,,,,, Carboplatin and Monthly Paclitaxel Carboplatin and Weekly Paclitaxel 8(1), 25-34 (2006) Masayoshi KOINUMA, Takahisa YAMANASHI, Miwako KAMEI, Makoto SHIRAGAMI, The realities and Medical Expense of

More information

デフレの定義(最新版).PDF

デフレの定義(最新版).PDF DP/01-1 Director General for Economic Assessment and Policy Analysis CABINET OFFICE E-mail : naoki.okamoto@mfs.cao.go.jp 1 2 3 i (ii) 4 5 Deflation defined as at least two consecutive years of price decreases.

More information

Jpn Pharmacol Ther vol. 31 no Panos Kanavos Director, International Health Policy, Dept. of Social Policy & LSE Health, London School of Econ

Jpn Pharmacol Ther vol. 31 no Panos Kanavos Director, International Health Policy, Dept. of Social Policy & LSE Health, London School of Econ Panos Kanavos Director, International Health Policy, Dept. of Social Policy & LSE Health, London School of Economics 1. Introduction ad hoc European Union: EU third party (a) (b) (c) (d) (e) value added

More information

診療ガイドラインのカラクリ

診療ガイドラインのカラクリ EBM EBM 2-3 (evidence-based medicine: EBM) EBM 1 1 1 2 B burden belief bargain barrier A. JAMA EBMer JAMA EBM 3 EBM 3 EBM 3 3 B. peer review Field(IOM) Shaneyfelt ( Guidelines Qualities Assessment Questionnaire:

More information

CHEMOTHERAPY Silver sulfadiazine (T 107) CHEMOTHERAPY Fig. 1 Item of patients Table 1 Criteria of bacteriological efficacy by the Committee xcellent: E Score of infection becomes to 0% at the end of medication.

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

untitled

untitled 1) American College of Surgeons:Advanced Trauma Life Support Course Manual. American College of Surgeons 1997;103-112 24 2) American Society of Anesthesiologists Task Force:Practice guideline for blood

More information

By Kenji Kinoshita, I taru Fukuda, Taiji Ota A Study on the Use of Overseas Construction Materials There are not few things which are superior in the price and the aspect of the quality to a domestic

More information

i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii

More information

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2) (1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46

More information

Microsoft Word - 表紙hara.doc

Microsoft Word - 表紙hara.doc Fertility Decline of SapporoDemographic Characteristics, Socio-Economic Backgrounds and Possibilities of Policy Interventions Toshihiko HARA, School of Design Keywords: fertility, family policy, time series

More information

平成14年8月22日

平成14年8月22日 7 14 11 26 7 18 7 7 ( ) 2 7 5 3 1. 1) 2) 3) 4) 5) 6) 2. 3. 4 4. 5. 6. 5 6 7 1. 8 2. 8 3. 12 4. 15 5. 19 6. 23 7. 26 8. 28 7 1. 2000 12 2 2000 12 6 7 2001 13 2 5 6 6 1) 2) 3) 4) 5) 6) 2. 2001 13 3 1) 8

More information

はじめに 転位の大きな大腿骨頚部骨折は, 高エネルギー外傷によっておこることや, 合併症の多い人におこることが多く, 治療も難しい

はじめに 転位の大きな大腿骨頚部骨折は, 高エネルギー外傷によっておこることや, 合併症の多い人におこることが多く, 治療も難しい ORIF or Arthroplasty for Displaced Femoral Neck Fractures in Patients Younger Than 65 Years Old An Economic Decision Analysis Eric Swart, MD et al. Investigation performed at the Department of Orthopaedic

More information

Ⅰ. 緒言 Suzuki, et al., Ⅱ. 研究方法 1. 対象および方法 1 6 表 1 1, 調査票の内容 図

Ⅰ. 緒言 Suzuki, et al., Ⅱ. 研究方法 1. 対象および方法 1 6 表 1 1, 調査票の内容 図 The Journal of the Japan Academy of Nursing Administration and Policies Vol 12, No 1, pp 515, 2008 原著 病棟勤務看護師の勤務状況とエラー ニアミスのリスク要因 Relationship between Risk Factors Related Medical Errors and Working Conditions

More information

- March IMF IMF IMF ITO The General Agreement on Tariffs and Trade

- March IMF IMF IMF ITO The General Agreement on Tariffs and Trade M&A IMF IMF gold tranche - March IMF IMF IMF ITO The General Agreement on Tariffs and Trade IMF IMF IMF GATT OECD OECD BITs. - March. U I = I (r m, i, Z * r m i Z * (= Z / Z) I / r m > I / i < I / Z *

More information

orororor oror CINAHL breast cancerhormonal therapyorendocrine therapyortamoxifenorgoserelinside effectorsymptomexperien

orororor oror CINAHL breast cancerhormonal therapyorendocrine therapyortamoxifenorgoserelinside effectorsymptomexperien 72017 3 資料 内分泌療法を受けている乳がん患者の苦痛体験に関する文献検討 A Literature Review regarding Distress Experienced by Breast Cancer Patients Undergoing Endocrine Therapy 四方文子 1), 鈴木久美 2) Ayako Shikata 1),Kumi Suzuki 2) キーワード

More information

The Japanese economy in FY2015 suffered from sluggish growth in individual consumption, while the foreign exchange market remained unstable with high volatility. Even in such an economic environment, MSF

More information

越智59.qxd

越智59.qxd Social Skills Training; SST SST Social Skills, SST, ;, SST, SST SST, ;, ; DeRosier & Marcus,, ;, a b SST Ladd & Mize, ; Hansen, Nagle, & Meyer,,, A BC SST SST SST SST SST SST, SST Goldstein & McGinnis,

More information

先導的大学改革推進委託事業調査研究報告書一覧 「諸外国における奨学制度に関する調査研究及び奨学金事業の社会的効果に関する調査研究」報告書(2)

先導的大学改革推進委託事業調査研究報告書一覧 「諸外国における奨学制度に関する調査研究及び奨学金事業の社会的効果に関する調査研究」報告書(2) 1951 scholarships 1960 1973 1 80 2001 1989 2 HECSHigher Education Contribution Scheme contribution = 1995 tuition fee (contribution) HECS HECS HECS 3 % Student Contribution amounts 4 HECS indexed 161 Beer

More information

2 / 24

2 / 24 2017 11 9 1 / 24 2 / 24 Solow, 1957 total factor productivity; TFP 5% 経済成長率の要因分解 4% 3% 2.68% 2.51% 2% 1% 0% 1.63% 1.50% 0.34% 0.42% 0.55% 0.97% 1.14% 0.86% 0.13% -0.59% -0.59% -0.09% 0.01% -1% 1970-80

More information

B : Total Cavo-Pulmonary Connection (TCPC) 1) Fontan F, Mounicot FB, Baudet E, Simonneau J, Gordo J, Gouffrant JM : ["Correction" of tricuspid atresia. 2 cases "corrected" using a new surgical technic].

More information

Microsoft Word - Šv”|.DOC

Microsoft Word - Šv”|.DOC ª ª * E-mail : shinobu.nakagawa@boj.or.jp ** E-mail : tomoko.katagiri@boj.or.jp i ii iii 1-1 70 6 2 90 1 1 1-2 90 2 3 90 1-1 70 3 1 2 93 97 98 98 98 98/4 3 1 1-2 35 1 80 90 25060 510 4 4 90 5 6 or 7 1

More information

untitled

untitled () 17 2 26 14:0017:00 500 14:0014:05 14:0515:05 14:0514:35 14:3515:05 15:0515:15 15:1516:15 15:1515:45 15:4516:15 16:1516:25 16:2517:00 1968 1973 1980 1988 2 MEMO 3 O2,CO2 4 10 11 12 5 13 14 15 16 17 18

More information

外国文学論集14号.indd

外国文学論集14号.indd 1876 1880 1 1930 1 1868 1930 1931 1945 1945 1989 1990 1868 1930 1930 1945 1945 1969 1970 1989 1990 1900 1901 1920 1946 1969 35 29 8.3 0.4 1908 1945 24 1951 1970 1931 1945 1951 5.6 27 0.8 1969 0.2 1910

More information

1272 CHEMOTHERAPY MAR. 1975

1272 CHEMOTHERAPY MAR. 1975 1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides

More information

1) Barat, I. u. Wagner, R.: Brauer, Beitrage Zur Klinik der Tub., Bd. 71 (1929) 2) Warnecke, F.: Zeitschr. f. Tbk. Bd. 54 (1929) 3) Leoni, Alfonso: Zbl. f. g. Tbk. Forsch. Bd. 33 (1930) 4) Jalavisto, Eva

More information

スライド 1

スライド 1 QOL 1 Goldberg, JCO 22:23-30, 2004 N9741: Oxaliplatin in First Line (US) IR 200 mg/m 2 OX 85 mg/m 2 every 3 weeks Efficacy IFL FOLFOX4 > IFL IROX FOLFOX4 IROX OS TTP RR 15.0 mo 6.9 mo 31 % P=0.0001 P=0.0014

More information

橡

橡 TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1

More information

審査報告書(案)

審査報告書(案) 19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET

More information

gofman2.eps

gofman2.eps 2011 7 10 4 7 1 ICRP(2007) 5.7 10 2 Sv 1 1 13 (=4600 =11 =660 ) 10mSv 5.7 10 4 4600[] =2.6[] ICRP 0 1 licrp 1 2 1 DDREF ICRP(2007) (ICRP 2007, p.178) - (idem., p.174) 1Sv - (DDREF: dose and dose-rate effectiveness

More information

日本職業・災害医学会会誌第51巻第5号

日本職業・災害医学会会誌第51巻第5号 Reprint request: TREATMENT FOR CALCANEAL FRACTURE Yumiko ISHIBASHI, Hiroshi HIEDA, Katsuya KANESAKI, Takashi TAMAKI, Yoshimasa HIRAI, Tojiro YANAGI and Yoshifumi KUNO Department of Orthopedic Surgery,

More information

GDPギャップと潜在成長率

GDPギャップと潜在成長率 2003 output gap 80 1 20 90 20 70 2 1 2 output gap potential output 1 2 (2001) 3 potential rate of growth 2000 Meyer (2000) European Central Bank: (1999b) 2002 10 4 3 (2000) 4 4 () 5 5 5 6 () () 7 Total

More information

606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man

606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man Dementia Japan 29 : 605-614, 2015 605 原著 要旨 1. はじめに 1 26 4.2 80 2 3 A survey of daycare facilities for dementia people in Japan Tohmi Osaki, Kiyoshi Maeda 1 650-0017 7-5 - 2 Medical Center for Dementia,

More information

終末期の呼吸困難症状への対応*松坂最終修正

終末期の呼吸困難症状への対応*松坂最終修正 Clinical Question 2017 5 27 1 PCOC 1. 12778 ( 55%, 45% NRS. 1 54, 35%. NRS. NRS,,,,,,,, Performance status, Ekstrom, M., et al.2016 J Pain Symptom Manage 51(5):816-23. . 1 85 ADL. 3,,,,. JCS200,, 40 /,

More information

And Business

And Business Discussion Papers In Economics And Business Discussion Paper 03-06 Graduate School of Economics and Osaka School of International Public Policy (OSIPP) Osaka University, Toyonaka, Osaka 560-0043, JAPAN

More information

日本職業・災害医学会会誌第51巻第1号

日本職業・災害医学会会誌第51巻第1号 内野ら 下腿骨骨折におけるハイブリッド創外固定器の有用性 31 図 2 軟部組織損傷程度と機能成績 Gustilo IIIB 以上の開放骨折では Gustilo IIIA 以下の開放骨折 及び皮下骨折よりも明らかに機能低下が認められた 図 1 年齢と機能成績 60 歳未満の若年者の方が明らかに良好な成績を示した a b c 図 3 a Gustilo Type IIIB b, c AO 分類 Type

More information

日本の高齢者世帯の貯蓄行動に関する実証分析

日本の高齢者世帯の貯蓄行動に関する実証分析 196 2017 * ** ** 1 2 3 JEL Classification Codes D14, D15, E21 Keywords * 28 Hyun- Hoon Lee Robert Owen Kwanho Shin ** 29 196 An Empirical Analysis of the Saving Behavior of Elderly Households in Japan

More information

untitled

untitled NTT 143-8540 5-21-16 Tel 03-3762-4151 Fax: 03-5493-5417 E-mail health@med.toho-u.ac.jp URL http://jhmtokyo.umin.jp 2 5 6 7 8 9 10 13 17 25 31 32 33 35 38 41 91 115 3 4 9 NPO 1999 5300 DPC BSC 9 2009 2

More information

Development of Induction and Exhaust Systems for Third-Era Honda Formula One Engines Induction and exhaust systems determine the amount of air intake

Development of Induction and Exhaust Systems for Third-Era Honda Formula One Engines Induction and exhaust systems determine the amount of air intake Development of Induction and Exhaust Systems for Third-Era Honda Formula One Engines Induction and exhaust systems determine the amount of air intake supplied to the engine, and as such are critical elements

More information

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

More information

untitled

untitled IV 1 IV 2 (i) 2 0.13 0.23 1 (i) 3 ( 0.11 0.19 0.5% 2 (ii) 1% (ii) 1,000, 1,000 (1 Q) G A 0.02 {e i ) 1} Q (e 5 1) 0.02 β Ρ (iii) 1 1 QG {e ig ( i G ) 1} QG (e 5 1) Ρ e in e i G n Q e in 1 e i G n 1 1 1

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

橡公共工事の発注システム ビジネスレビュー.PDF

橡公共工事の発注システム ビジネスレビュー.PDF 47 4 1993 (1) (2) (3) (4) (5) (6) 1 - 2 1-1993 5 20 1 3 2 Private Finance Initiative 2 1999 7 23-1997 Procurement Guidance 4 1 Government Construction Procurement Guidance, HM Treasury, U.K., 1997 Investment

More information

Understanding Stem Cell Transplant 2007

Understanding Stem Cell Transplant 2007 Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454

More information

(1) (2) 27 7 15 (1) (2), E-mail: bessho@econ.keio.ac.jp 1 2 1.1......................................... 2 1.2............................... 2 1.3............................... 3 1.4............................

More information

CO CO2 1 CO2 CO2 CO2 CO CO2 CO2 CO2 9 3CO2 CO2 a, b2 a a1 a2 a3 a4 b a 3 ELC-CO2 CO2 CO2 CO2 Vol.2 No Spring 3

CO CO2 1 CO2 CO2 CO2 CO CO2 CO2 CO2 9 3CO2 CO2 a, b2 a a1 a2 a3 a4 b a 3 ELC-CO2 CO2 CO2 CO2 Vol.2 No Spring 3 CO2 CO2 CO2 LCA HAYASHI, Yoshitsugu KATO, Hirokazu UENO, Yoichi 1 CO2 2 CO2 1 3 2 1 1 8 6 4 2 4 2 % 89 1975 198 199 CO2 CO2 2 CO2 1 1989 35,7 CO2 21 26. 5 1 15 19971 19.4 115. 12.6 117.2 1,5cc1,2kg15 12km/l1,km1

More information

海外投資と経営

海外投資と経営 ()1999 246 (1)(2) 55 (3) (1) (2)(3)(4) (5) 48 (1) (3) 48 1999-8 49 146 56 CEO C E O 57 2000 1997 19206263 209 () 3 1 124 58 (1) (2) 2 59 () () () () () (3) 60 61 50 () 3 1987 203 50 3 1987 199 199201 62

More information